This is the lesson where the philosophy becomes an operating system.

ICH E6(R3) Section 3.10 provides the most comprehensive quality management framework in the history of Good Clinical Practice guidance. But here is the problem: the language is written for sponsors. The six components of risk management in Section 3.10.1 describe what a pharmaceutical company or CRO should do at the program level. Nowhere does the guideline hand you, the regulatory coordinator at an investigator site, a ready-made adaptation for your own operations.

That adaptation is what we build in this lesson. I will walk you through each of the six risk management components -- identification, evaluation, control, communication, review, and reporting -- and show you what each one looks like when the RC applies it to site-level regulatory operations. And then we will address a concept that I find most training programs treat too abstractly: Critical to Quality factors, and specifically how sponsor-level CTQ factors cascade down to become site-level CTQ factors that the RC must protect across an entire portfolio.

This is the lesson where the philosophy becomes an operating system.

ICH E6(R3) Section 3.10 provides the most comprehensive quality management framework in the history of Good Clinical Practice guidance. But here is the problem: the language is written for sponsors. The six components of risk management in Section 3.10.1 describe what a pharmaceutical company or CRO should do at the program level. Nowhere does the guideline hand you, the regulatory coordinator at an investigator site, a ready-made adaptation for your own operations.

That adaptation is what we build in this lesson. I will walk you through each of the six risk management components -- identification, evaluation, control, communication, review, and reporting -- and show you what each one looks like when the RC applies it to site-level regulatory operations. And then we will address a concept that I find most training programs treat too abstractly: Critical to Quality factors, and specifically how sponsor-level CTQ factors cascade down to become site-level CTQ factors that the RC must protect across an entire portfolio.